NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

This study looked at the long-term safety of faricimab, an injected eye medication, in over 1,000 people with wet age-related macular degeneration (AMD). Participants had already completed earlier studies and continued receiving faricimab at personalized intervals. The main goal …

This study tested a new medicine called LUBT010 against the standard drug Lucentis for people with wet age-related macular degeneration, a leading cause of vision loss. About 600 adults aged 50 and older received monthly injections into the eye for one year. The goal was to see i…

This study tested whether a new drug called FYB203 works as well as the standard treatment Eylea for people with wet age-related macular degeneration, a condition that causes vision loss. 434 adults aged 50 and older took part. The main goal was to see if vision improved after 8 …

This early-stage study tested a new drug called OLX10212 in 21 people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The main goal was to see if the eye injections are safe and tolerable. Researchers also looked for early signs that the drug migh…

This study tested three different doses of SYL1801 eye drops in 99 people with wet age-related macular degeneration (AMD). The goal was to see if the drops are safe and can help maintain or improve vision. Participants received the eye drops and were followed for 42 days to measu…

This early-stage study tested a new drug called PMC-403 in 17 people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The main goal was to check the drug's safety and find the best dose for future studies. Participants received the drug by injectio…

This study looked at how much of the eye medicine aflibercept enters the bloodstream when given as injections into both eyes. It included 51 adults with diabetic macular edema or age-related macular degeneration. The goal was to measure drug levels in the blood, not to test if th…

This study measured the thickness of the conjunctiva and Tenon's capsule (layers on the front of the eye) in 736 people with wet age-related macular degeneration or diabetic macular edema, as well as in healthy adults of similar age. Researchers used a special eye scanner (SD-OCT…